Higher blood levels of bile acids, molecules that aid fat absorption in the gut, are linked to slower MS progression, per ...

Candidates throughout the campaigns promised to provide a platform for the people of Kisoro so that their issues are heard ...

Other MS patients, a minority, have a form of the disease that features gradually increasing progressive disability from onset—so-called primary progressive MS (PPMS). While effective disease ...

DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...

"I'm just, I'm frustrated," said Rhonda Mirabella.Rhonda Mirabella is masking her emotions. She's hurt and angry with the ...

Drugmakers had hoped that inhibiting receptor-interacting protein kinase would decrease inflammation and reduce neuronal degeneration in patients with multiple sclerosis and other neurodegenerative co ...

There are signs that society is moving away from the progressive left’s often strict expectations about how to discuss ...

Medically reviewed by Huma Sheikh, MDMedically reviewed by Huma Sheikh, MD Primary progressive multiple sclerosis (PPMS) is a ...

This exploratory study assessed the safety and clinical benefit of masitinib in the treatment of primary progressive MS (PPMS) or relapse-free secondary progressive MS (rfSPMS). Methods ...

After a series of tests and a lumbar puncture, Mr Foniadakis was told he had “one of the worst kinds” of multiple sclerosis — ...

with the HERCULES trial meeting its primary endpoint while the GEMINI trials did not. The HERCULES study focused on the efficacy and safety of tolebrutinib in individuals with non-relapsing secondary ...

NEW YORK, November 7, 2024 – Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and ...